{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:06:32Z","timestamp":1790885192581,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health-National Institute on Drug Abuse Research Center","award":["P60-DA05130"],"award-info":[{"award-number":["P60-DA05130"]}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["UL1RR024143"],"award-info":[{"award-number":["UL1RR024143"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.brainres.2009.11.015","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T09:14:46Z","timestamp":1258103686000},"page":"235-252","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases"],"prefix":"10.1016","volume":"1314","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Proudnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Yuferov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2009.11.015_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of \u03bc-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.66020443.x","article-title":"Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions","volume":"66","author":"Azaryan","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2009.11.015_bib3","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.2337\/diabetes.54.8.2492","article-title":"Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study","volume":"54","author":"Baker","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.brainres.2009.11.015_bib4","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1073\/pnas.0710225105","article-title":"Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates","volume":"105","author":"Barr","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001504","article-title":"Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden","volume":"9","author":"Bart","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","article-title":"Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1038\/sj.npp.1301128","article-title":"Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the mu opioid receptor gene","volume":"31","author":"Bart","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"\u03bc opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0889-8529(18)30079-3","article-title":"Proopiomelanocortin-derived peptides","volume":"23","author":"Bertagna","year":"1994","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.brainres.2009.11.015_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2006.01.007","article-title":"A role for beta-melanocyte-stimulating hormone in human body-weight regulation","volume":"3","author":"Biebermann","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib11","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1300\/J069v14n03_06","article-title":"Availability of reliable serum methadone determination for management of symptomatic patients","volume":"14","author":"Borg","year":"1995","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.brainres.2009.11.015_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2009.11.015_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3565(25)22944-5","article-title":"Monoamine mediation of cocaine-induced hypothalamo\u2013pituitary\u2013adrenal activation","volume":"256","author":"Borowsky","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib15","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","article-title":"Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior","volume":"102","author":"Boutrel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archgenpsychiatry.2009.9","article-title":"Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals","volume":"66","author":"Brady","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0006-8993(90)90066-K","article-title":"Effects of morphine treatment on proopiomelanocortin systems in rat brain","volume":"519","author":"Bronstein","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3181\/00379727-164-40861","article-title":"Thrombocytosis in the offspring of female mice receiving dl-methadone","volume":"164","author":"Burstein","year":"1980","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.brainres.2009.11.015_bib19","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/hmg\/11.17.1997","article-title":"A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism","volume":"11","author":"Challis","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2009.11.015_bib20","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1073\/pnas.0809918106","article-title":"MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family","volume":"106","author":"Chan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib21","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1021\/bi700125e","article-title":"Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling","volume":"46","author":"Chen","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2009.11.015_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.npp.1300856","article-title":"The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress","volume":"31","author":"Chong","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib23","doi-asserted-by":"crossref","first-page":"RC168","DOI":"10.1523\/JNEUROSCI.21-19-j0003.2001","article-title":"Orexin (hypocretin) neurons contain dynorphin","volume":"21","author":"Chou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.11.015_bib24","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2008-1164","article-title":"Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene","volume":"93","author":"Cl\u00e9ment","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib25","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1210\/jc.2008-0954","article-title":"Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway","volume":"93","author":"Creemers","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0026-0495(97)90289-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone induced withdrawal","volume":"46","author":"Culpepper-Morgan","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.brainres.2009.11.015_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","article-title":"Treatment of opioid induced constipation with oral naloxone: a pilot study","volume":"23","author":"Culpepper-Morgan","year":"1992","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib28","series-title":"Narcotics and the Hypothalamus","first-page":"161","article-title":"Some endocrinologic observations in narcotics addicts","author":"Cushman","year":"1974"},{"key":"10.1016\/j.brainres.2009.11.015_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","article-title":"Narcotic blockade","volume":"118","author":"Dole","year":"1966","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.brainres.2009.11.015_bib31","first-page":"2766","article-title":"Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype","volume":"84","author":"Elias","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(97)00348-3","article-title":"Proopiomelanocortin (POMC) mRNA expression: distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus","volume":"55","author":"Fang","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib33","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/db06-0214","article-title":"Heterozygosity for a POMC-null mutation and increased obesity risk in humans","volume":"55","author":"Farooqi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.brainres.2009.11.015_bib34","first-page":"502","article-title":"Variable dose naltrexone induced HPA stimulation in abstinent alcoholics: a preliminary study","volume":"23","author":"Farren","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib35","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.11.015_bib36","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","article-title":"Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving","volume":"57","author":"Gorelick","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-008-1225-5","article-title":"Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence","volume":"200","author":"Gorelick","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2009.11.015_bib38","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2009.11.015_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.10054","article-title":"Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1)","volume":"118B","author":"Hernandez-Avila","year":"2003","journal-title":"Am. J. Med. Genet., B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.brainres.2009.11.015_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0022-3565(25)23071-3","article-title":"Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo\u2013pituitary\u2013adrenal axis secretion in the rat","volume":"225","author":"Ignar","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-1033.1984.tb08306.x","article-title":"Tissue distribution of messenger RNAs coding for opioid peptide precursors and related RNA","volume":"142","author":"Jingami","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.brainres.2009.11.015_bib43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1530\/REP-06-0359","article-title":"Effects of ACTH and expression of the melanocortin-2 receptor in the neonatal mouse testis","volume":"133","author":"Johnston","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.brainres.2009.11.015_bib44","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/endo.142.8.8299","article-title":"Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats","volume":"142","author":"J\u00f6hren","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-3223(86)90150-2","article-title":"Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts","volume":"21","author":"Kosten","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0024-3205(86)90437-6","article-title":"A preliminary study of beta-endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts","volume":"39","author":"Kosten","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2009.11.015_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","article-title":"Medical safety and side effects of methadone in tolerant individuals","volume":"223","author":"Kreek","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2009.11.015_bib49","first-page":"2773","article-title":"Plasma and urine levels of methadone","volume":"73","author":"Kreek","year":"1973","journal-title":"N.Y. State J. Med."},{"key":"10.1016\/j.brainres.2009.11.015_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1978.tb16769.x","article-title":"Medical complications in methadone patients","volume":"311","author":"Kreek","year":"1978","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"Suppl.","key":"10.1016\/j.brainres.2009.11.015_bib51","first-page":"1","article-title":"Methadone disposition during the perinatal period in humans","volume":"ll","author":"Kreek","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib52","first-page":"232","article-title":"Opiates, opioids and addiction","volume":"1","author":"Kreek","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib53","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/BF02532387","article-title":"Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity and in specific addictive diseases","volume":"21","author":"Kreek","year":"1996","journal-title":"J. Neurochem. Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0091-3057(96)00440-6","article-title":"Opiate and cocaine addictions: challenge for pharmacotherapies","volume":"57","author":"Kreek","year":"1997","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","article-title":"Methadone-related opioid agonist pharmacotherapy for heroin addiction: history, recent molecular and neurochemical research and the future in mainstream medicine","volume":"909","author":"Kreek","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2009.11.015_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/clpt.2008.5","article-title":"Role of a functional human gene polymorphism in stress responsivity and addictions","volume":"83","author":"Kreek","year":"2008","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","article-title":"Drug dependence: stress and dysregulation of brain reward pathways","volume":"51","author":"Kreek","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainres.2009.11.015_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/mi.7.2.7","article-title":"Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene","volume":"7","author":"Kreek","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.brainres.2009.11.015_bib59","series-title":"Advances in Endogenous and Exogenous Opioids","first-page":"364","article-title":"Effects of chronic exogenous opioid administration on levels of one endogenous opioid (beta-endorphin) in man","author":"Kreek","year":"1981"},{"key":"10.1016\/j.brainres.2009.11.015_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(83)91684-7","article-title":"Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation","volume":"5","author":"Kreek","year":"1983","journal-title":"Lancet Feb."},{"key":"10.1016\/j.brainres.2009.11.015_bib61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0024-3205(83)90529-5","article-title":"Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans","volume":"33","author":"Kreek","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2009.11.015_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0143-4179(84)90081-7","article-title":"ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans","volume":"5","author":"Kreek","year":"1984","journal-title":"Neuropeptides"},{"key":"10.1016\/j.brainres.2009.11.015_bib63","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat. Rev., Drug Discov."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2009.11.015_bib64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2004.07.024","article-title":"Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA","volume":"47","author":"Kreek","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2009.11.015_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuropharm.2008.07.042","article-title":"Bidirectional translational research: progress in understanding addictive diseases","volume":"56","author":"Kreek","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1471-4159.2007.04738.x","article-title":"The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor","volume":"103","author":"Kroslak","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2009.11.015_bib68","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1210\/jc.2003-030502","article-title":"Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4\u201310","volume":"88","author":"Krude","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(00)00819-0","article-title":"Opioid receptor and peptide gene polymorphisms: potential implications for addictions","volume":"410","author":"LaForge","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2009.11.015_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2006.01.006","article-title":"A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance","volume":"3","author":"Lee","year":"2006","journal-title":"Cell. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib71","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.npp.1300927","article-title":"Effects of high dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain","volume":"31","author":"Leri","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.euroneuro.2008.09.004","article-title":"Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain","volume":"19","author":"Leri","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2009.11.015_bib73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: a candidate-gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib74","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1601-183X.2009.00501.x","article-title":"Heroin addiction in African Americans: a hypothesis-driven association study","volume":"8","author":"Levran","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jcem.85.3.6454","article-title":"Origin of an ovarian steroid cell tumor causing isosexual pseudoprecocious puberty demonstrated by the expression of adrenal steroidogenic enzymes and adrenocorticotropin receptor","volume":"85","author":"Lin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib76","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.0901800106","article-title":"Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior","volume":"106","author":"Mague","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib77","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)24454-8","article-title":"Chronic administration of a cocaine \u201cbinge\u201d alters basal dopamine extracellular levels in male rats: an in vivo microdialysis study","volume":"272","author":"Maisonneuve","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib78","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1073\/pnas.0812491106","article-title":"Tissue plasminogen activator modulates the cellular and behavioral response to cocaine","volume":"106","author":"Maiya","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4530(80)90003-7","article-title":"Steroid hormones and the brain: cellular mechanisms underlying neural and behavioral plasticity","volume":"5","author":"McEwen","year":"1980","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/S0007125000296645","article-title":"The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress","volume":"15","author":"McEwen","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.mp.4001378","article-title":"A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression","volume":"9","author":"Miller","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02896854","article-title":"Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats","volume":"1","author":"Mocchetti","year":"1989","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2009.11.015_bib83","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic systems in the activation of mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.11.015_bib84","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.095380","article-title":"Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone","volume":"317","author":"Negus","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib85","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/npp.2008.127","article-title":"Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs. food choice in heroin-dependent rhesus monkeys","volume":"34","author":"Negus","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.mp.4002147","article-title":"Genotype patterns that contribute to increased risk for or protection from developing heroin addiction","volume":"13","author":"Nielsen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00429-005-0066-9","article-title":"Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs","volume":"211","author":"Nimura","year":"2006","journal-title":"Anat. Embryol. (Berl.)"},{"key":"10.1016\/j.brainres.2009.11.015_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol dependent subjects and activates the hypothalamo\u2013pituitary\u2013adrenocortical axis","volume":"160","author":"O\u2019Malley","year":"2004","journal-title":"Psychopharmacology. (Berl.)"},{"key":"10.1016\/j.brainres.2009.11.015_bib89","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J069v25n01_07","article-title":"High methadone dose significantly reduces cocaine abuse in methadone maintenance treatment (MMT) patients","volume":"25","author":"Peles","year":"2006","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.brainres.2009.11.015_bib91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2008.02.042","article-title":"Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction","volume":"435","author":"Proudnikov","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.11.015_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-4328(98)00073-4","article-title":"Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats","volume":"101","author":"Qui\u00f1ones-Jenab","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib93","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0091-3057(00)00381-6","article-title":"Ovarian hormone replacement affects cocaine-induced behaviors in ovariectomized female rats","volume":"67","author":"Qui\u00f1ones-Jenab","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib94","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(00)00213-6","article-title":"Cocaine affects progesterone plasma levels in female rats","volume":"66","author":"Qui\u00f1ones-Jenab","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2009.11.015_bib95","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000123556","article-title":"Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat","volume":"37","author":"Ragavan","year":"1983","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib96","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/eje.1.02015","article-title":"Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion","volume":"153","author":"Reisch","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.brainres.2009.11.015_bib97","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0006-3223(98)00259-5","article-title":"The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers","volume":"45","author":"Rosen","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib98","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1530-0277.1998.tb03931.x","article-title":"Nalmefene causes greater hypothalamic\u2013pituitary\u2013adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism","volume":"22","author":"Schluger","year":"1998","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib99","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0893-133X(00)00222-0","article-title":"Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction","volume":"24","author":"Schluger","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.162.2.340","article-title":"Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence","volume":"162","author":"Schottenfeld","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib101","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib102","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","article-title":"Stress induced cocaine craving and hypothalamic\u2013pituitary\u2013adrenal responses are predictive of cocaine relapse outcomes","volume":"63","author":"Sinha","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib103","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2003-032010","article-title":"Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH","volume":"89","author":"Slawik","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib104","first-page":"2746","article-title":"ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin","volume":"81","author":"Slominski","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2009.11.015_bib105","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.11.015_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","article-title":"\u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen","volume":"19","author":"Spangler","year":"1993","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-4328(96)02257-7","article-title":"Behavioral stereotypies induced by \u201cbinge\u201d cocaine administration are independent of drug-induced increases in corticosterone levels","volume":"86","author":"Spangler","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib108","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1176\/ajp.148.9.1268a","article-title":"Methadone dose for cocaine abuse","volume":"148","author":"Stine","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2009.11.015_bib109","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02247469","article-title":"Buprenorphine versus methadone in the treatment of opioid dependent cocaine users","volume":"116","author":"Strain","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib110","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1093\/nar\/11.19.6847","article-title":"Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene","volume":"11","author":"Takahashi","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptor mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2009.11.015_bib112","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1172\/JCI116853","article-title":"Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene","volume":"92","author":"Tsigos","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2009.11.015_bib113","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","article-title":"Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors","volume":"5","author":"Unterwald","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2009.11.015_bib114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10519-008-9207-2","article-title":"Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque","volume":"38","author":"Vallender","year":"2008","journal-title":"Behav. Genet."},{"key":"10.1016\/j.brainres.2009.11.015_bib115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0306-4530(80)90026-8","article-title":"Short-term hormonal effects of naloxone in man","volume":"5","author":"Volavka","year":"1980","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib116","first-page":"8","article-title":"Prevalence of melanocortin system transcripts in rat salt homeostasis endocrine tissues","volume":"15","author":"Wachira","year":"2007","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.brainres.2009.11.015_bib117","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0169-328X(96)00084-8","article-title":"Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus","volume":"41","author":"Wardlaw","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib118","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/en.2008-0941","article-title":"Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking","volume":"150","author":"Webb","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001090050246","article-title":"The human mu opioid receptor gene: 5\u2032 regulatory and intronic sequences","volume":"76","author":"Wendel","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.brainres.2009.11.015_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300290","article-title":"Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin","volume":"29","author":"Wigger","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib121","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000093126","article-title":"Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells","volume":"82","author":"Willenberg","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib122","doi-asserted-by":"crossref","first-page":"R1120","DOI":"10.1152\/ajpregu.00240.2007","article-title":"Structural insights into the role of the ACTH receptor cysteine residues on receptor function","volume":"293","author":"Yang","year":"2007","journal-title":"Am. J. Physiol., Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.brainres.2009.11.015_bib123","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0361-9230(98)00155-5","article-title":"Acute \u201cbinge\u201d cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system","volume":"48","author":"Yuferov","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2009.11.015_bib124","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","article-title":"Effect of the endogenous kappa opioid agonist dynorphin A(1\u201317) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"172","author":"Zhang","year":"2004","journal-title":"Psychopharmacology. (Berl.)"},{"key":"10.1016\/j.brainres.2009.11.015_bib125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuroscience.2008.09.039","article-title":"mu Opioid receptor knockdown in the substantia nigra\/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin","volume":"158","author":"Zhang","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2009.11.015_bib126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(96)00672-3","article-title":"Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelancortin","volume":"315","author":"Zhou","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2009.11.015_bib127","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3565(25)20974-0","article-title":"Corticotropin-releasing factor and type 1 corticotropin releasing factor receptor messenger RNAs in rat brain and pituitary during \u201cbinge\u201d-pattern cocaine administration and chronic withdrawal","volume":"279","author":"Zhou","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.11.015_bib128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.0.1630261","article-title":"Hypothalamic\u2013pituitary\u2013adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress","volume":"163","author":"Zhou","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.brainres.2009.11.015_bib129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000054476","article-title":"Effects of chronic \u201cbinge\u201d cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32","volume":"70","author":"Zhou","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.brainres.2009.11.015_bib130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0169-328X(03)00139-6","article-title":"Increased CRH mRNA levels in the rat amygdala during acute withdrawal from chronic \u201cbinge\u201d cocaine","volume":"114","author":"Zhou","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(02)03929-X","article-title":"Alterations in hypothalamic\u2013pituitary\u2013adrenal axis activity and in levels of POMC and CRH-R1 mRNAs in the pituitary and hypothalamus of the rat during chronic \u201cbinge\u201d cocaine and withdrawal","volume":"964","author":"Zhou","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib132","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molbrainres.2004.07.008","article-title":"Effects of selective D1- or D2-like dopamine receptor antagonists with acute \u201cbinge\u201d pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus","volume":"130","author":"Zhou","year":"2004","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainres.2009.11.015_bib133","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.neuroscience.2005.05.032","article-title":"Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation","volume":"134","author":"Zhou","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2009.11.015_bib134","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1677\/joe.1.06960","article-title":"mu Opioid receptor and orexin\/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal","volume":"191","author":"Zhou","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.brainres.2009.11.015_bib135","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.neuroscience.2008.03.023","article-title":"Effects of cocaine place conditioning, chronic escalating-dose \u201cbinge\u201d pattern cocaine administration and acute withdrawal on orexin\/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague\u2013Dawley rats","volume":"153","author":"Zhou","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2009.11.015_bib136","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.npp.1301419","article-title":"Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin","volume":"33","author":"Zhou","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2009.11.015_bib137","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm1196-1225","article-title":"Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving","volume":"2","author":"Zubieta","year":"1996","journal-title":"Nat. Med."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689930902407X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689930902407X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:17:13Z","timestamp":1739427433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689930902407X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":138,"alternative-id":["S000689930902407X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2009.11.015","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}